A decade of achievement in pulmonary hypertension - PubMed (original) (raw)

Editorial

A decade of achievement in pulmonary hypertension

M Humbert et al. Eur Respir Rev. 2011 Dec.

No abstract available

PubMed Disclaimer

Conflict of interest statement

Statement of Interest

M. Humbert has relationships with drug companies including Actelion, AstraZeneca, Bayer-Schering, Chiesi, GSK, Lilly, MSD, Novartis, Nycomed, Pfizer and United Therapeutics. In addition to being an investigator in trials involving these companies, relationships include consultancy service and membership of scientific advisory boards. G. Simonneau has relationships with drug companies including Actelion, Bayer-Schering, GSK, Lilly, Novartis, Pfizer and United Therapeutics. In addition to being an investigator in trials involving these companies, relationships include consultancy service and membership of scientific advisory boards. L. J. Rubin has acted on a scientific advisory committee for United Therapeutics and has acted as a consultant for NHLBI, Actelion, Pfizer, United Therapecthics, LungRx, Gilead, Aires Pharmaceuticals, GSK, Bayer, GeNO and Cytokinetics. He holds shares for United Therapeutics.

Similar articles

• New horizons in pulmonary arterial hypertension management.
  McLaughlin V, Simonneau G, Galiè N, Rubin LJ. McLaughlin V, et al. Eur Respir Rev. 2014 Dec;23(134):408-9. doi: 10.1183/09059180.00007614. Eur Respir Rev. 2014. PMID: 25445938 Free PMC article. No abstract available.
• Recent advances in the treatment of pulmonary hypertension.
  Broberg C, Gatzoulis M. Broberg C, et al. Hellenic J Cardiol. 2005 May-Jun;46(3):165-73. Hellenic J Cardiol. 2005. PMID: 15981551 Review. No abstract available.
• Looking to the future: a new decade of pulmonary arterial hypertension therapy.
  McLaughlin VV. McLaughlin VV. Eur Respir Rev. 2011 Dec;20(122):262-9. doi: 10.1183/09059180.00006411. Eur Respir Rev. 2011. PMID: 22130819 Free PMC article. Review.
• Pulmonary arterial hypertension.
  Rubin LJ. Rubin LJ. Proc Am Thorac Soc. 2006;3(1):111-5. doi: 10.1513/pats.200510-112JH. Proc Am Thorac Soc. 2006. PMID: 16493158 Review.
• Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland.
  National Pulmonary Hypertension Centres of the UK and Ireland. National Pulmonary Hypertension Centres of the UK and Ireland. Thorax. 2008 Mar;63 Suppl 2:ii1-ii41. doi: 10.1136/thx.2007.090480. Thorax. 2008. PMID: 18308974 No abstract available.

Cited by

• You say goodbye, and I say hello!
  Humbert M. Humbert M. Eur Respir Rev. 2012 Dec 1;21(126):265-6. doi: 10.1183/09059180.00006112. Eur Respir Rev. 2012. PMID: 23204115 Free PMC article. No abstract available.
• Pulmonary hypertension surveillance: United States, 2001 to 2010.
  George MG, Schieb LJ, Ayala C, Talwalkar A, Levant S. George MG, et al. Chest. 2014 Aug;146(2):476-495. doi: 10.1378/chest.14-0527. Chest. 2014. PMID: 24700091 Free PMC article.
• Future perspectives in pulmonary arterial hypertension.
  Simonneau G, Hoeper MM, McLaughlin V, Rubin L, Galiè N. Simonneau G, et al. Eur Respir Rev. 2016 Dec;25(142):381-389. doi: 10.1183/16000617.0084-2016. Eur Respir Rev. 2016. PMID: 27903660 Free PMC article. Review.
• Understanding the impact of pulmonary arterial hypertension on patients' and carers' lives.
  Guillevin L, Armstrong I, Aldrighetti R, Howard LS, Ryftenius H, Fischer A, Lombardi S, Studer S, Ferrari P. Guillevin L, et al. Eur Respir Rev. 2013 Dec;22(130):535-42. doi: 10.1183/09059180.00005713. Eur Respir Rev. 2013. PMID: 24293469 Free PMC article. Review.
• Pulmonary hypertension: From an orphan disease to a global epidemic.
  Butrous G. Butrous G. Glob Cardiol Sci Pract. 2020 Apr 30;2020(1):e202005. doi: 10.21542/gcsp.2020.5. Glob Cardiol Sci Pract. 2020. PMID: 33150150 Free PMC article. Review. No abstract available.

References

1. 1. Aronson JK. Rare diseases and orphan drugs. Br J Clin Pharmacol 2006; 61: 243–245. - PMC - PubMed
2. 1. Jardim C, Hoette S, Souza R. Contemporary issues in pulmonary hypertension. Eur Respir Rev 2010; 19: 266–271. - PMC - PubMed
3. 1. Hatano S, Strasser T. Primary Pulmonary Hypertension. Geneva, World Health Organization, 1975.
4. 1. Simonneau G, Galiè N, Rubin LJ, et al. . Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43: Suppl. 12, 5S–12S. - PubMed
5. 1. Simonneau G, Robbins IM, Beghetti M, et al. . Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009; 54: Suppl. 1, S43–S54. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • HighWire
  • PubMed Central

• Medical

  • MedlinePlus Health Information